Curcumin suppresses glioblastoma progression
ENO1 could be a possible target of curcumin in the suppression of GBM cells- read the full article online
Stay updated with breaking news from Analysis Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ENO1 could be a possible target of curcumin in the suppression of GBM cells- read the full article online
Xtalks Announces Its Life Science Webinar Calendar for June 2021 Share Article Upcoming free, educational webinars from Xtalks Webinars will feature topics on biomarkers, clinical trials, drug discovery & development, healthcare, laboratory technology, patient recruitment & retention, pharmaceutical, pharma manufacturing & supply chain, medical devices and food. TORONTO (PRWEB) June 01, 2021 Stay on top of current hot topics through free webinars presented by leading experts in pharma, biotech, medical device and food industries...
The "Global Liquid Biopsy Market by Clinical Application, Therapeutic Application, Biomarker Type, Analysis Platform, Analysis Purpose, Product, Industry Verticals, and Geography - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
Network Pharmacological Mechanism Research of Herba Drynariae Rhizoma-Epimedii Folium in Treating Osteoarthritis Zonghui Dai 2Department of Orthopedics, Jingzhou Central Hospital, Second Clinical Medical Hospital, Yangtze University, Jingzhou, China Copyright © 2021 by author(s) and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY 4.0). ABSTRACT Objective: To investigate the potential mechanism of Drynariae Rhizoma-Epimedii Folium in the treatment of osteoarthritis (OA) based on network pharmacology. Methods: The po...
Share this article Share this article ResearchAndMarkets.com's offering. The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted). Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising for the following liquid biopsy applications: noninvasive prenatal screening for average-risk populat...